In recent years, it has become evident that loss of apical membranous CEACAM1 expression with a concomitant shift to intra-cytoplasmic localization corresponds to decreased relapse-free survival of HCC after liver transplantation [74]. This evidence concerns the gene CEACAM1 and hepatocellular carcinoma.